CompletedPhase 4NCT01263938

Modulation of Monocyte Activation by Atorvastatin in HIV Infection

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Pennsylvania
Principal Investigator
Ronald G Collman, MD
University of Pennsylvania
Intervention
Atorvastatin(drug)
Enrollment
5 enrolled
Eligibility
18 years · All sexes
Timeline
2011 – 2017

Study locations (1)

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01263938 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials